al., reported a decrease of PD-L1 in early stages of therapy [62], which could be related to the elimination of tumor cells, and an increase of PD1 expression in immune cells that would suggest an activation of T cells [104, 105], however, Lee, et. Here, CD274 is linked to neoplasm.